News

A Note from Dr. Mario Raviglione


10 Feb 2010
by Working Group

Dr. Mario Raviglione
Dr. Mario Raviglione

Never before in the recent history of tuberculosis research have we been so close to seeing the arrival of new drug breakthroughs that could help reshape the course of TB care and control in a direct and positive way. WHO is fully supportive of the impressive efforts and energies that have been invested by the scientific community over the last decade in the search for new and more effective anti-TB drugs.

The contribution to TB control from this research community will have a far-reaching impact on the lives of millions in the future, and we all hope that the continued challenges in developing new drugs can be overcome swiftly as the need is urgent.

We welcome the launch of this website and look forward to accessing regular up-to-date information about the progress and achievements of the New Drug working group and helping to share this information with the world at large.

— Dr. Mario Raviglione, Director of WHO Stop TB Department

More News
23 Aug 2022
The PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings together non-...
4 May 2022
Earlier this week, the World Health Organization (WHO) released a rapid communication which detailed the upcoming changes to the treatment guidance for drug-resistant tuberculosis (DR-TB). These guidelines are used to inform national TB programmes globally on how to treat patients with these...
5 Apr 2022
On April 01, 2022, the Stop TB Partnership launched the second online consultation for the new Global Plan to End TB 2023-2030. Over the years, the Global Plans have been important tools for advocacy and resource mobilization, and served as a reference document for donors and stakeholders. In May...